We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Tianlong’s cutting-edge products and innovative molecular diagnostic solutions are on display at MEDICA 2023 (Photo courtesy of Tianlong)
Image: Tianlong’s cutting-edge products and innovative molecular diagnostic solutions are on display at MEDICA 2023 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) is showcasing its cutting-edge products and innovative molecular diagnostic solutions at MEDICA 2023. The company is also highlighting its classic integrated PCR lab solution and its brand new product - Panall 8000 All-in-One Molecular Diagnosis System at the show. The revolutionary Panall 8000 All-in-One Molecular Diagnosis System seamlessly integrates various diagnostic stages, setting new standards for efficiency and accuracy in the field of molecular diagnostics.

Tianlong is also exhibiting the RBT320 Agglutination Automated Detection System which is intended for the detection of Brucellosis based on the Rose Bengal Test (RBT) method. Designed for automating laboratory workflow, Tianlong RBT320 integrates various functions, including automatic sample loading, sample mixing, photographing, AI image recognition, and result interpretation. With optimized efficiency, RBT320 can process 320 samples per hour and is suitable for large-scale screening of Brucella antibodies. Tianlong RBT320 is highly automated and can empower labs with maximum efficiency and effectively avoid human errors, while the use of the RBT method can also be cost-effective for labs.

At MEDICA 2023, Tianlong is also presenting the iGeneCase 1600 Diagnostics-in-a-Suitcase, and PANA 9600X Automated Nucleic Acid Workstation, as well as a variety of products and compatible reagents. For instance, Tianlong's solution for nucleic acid detection of influenza virus is designed to identify and differentiate various strains, including Influenza A/B, Influenza C, Influenza A(H1&H3), Influenza A(H1N1), Influenza A(H3N2), and Influenza A(H5N1), as well as multiplex kit for Influenza A/B/Human Adenovirus/2019-nCoV. This comprehensive solution provides a scientific basis for accurate diagnosis and treatment of individuals with symptoms of influenza.

Related Links:
Tianlong Science and Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.